Candriam SCA’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $96.2M | Sell |
656,423
-52,699
| -7% | -$7.67M | 0.43% | 45 |
|
|
2026
Q1 | $102M | Buy |
709,122
+39,614
| +6% | +$6.01M | 0.53% | 35 |
|
|
2025
Q4 | $96M | Sell |
669,508
-231,200
| -26% | -$34.1M | 0.48% | 42 |
|
|
2025
Q3 | $138M | Sell |
900,708
-191,990
| -18% | -$30M | 0.72% | 22 |
|
|
2025
Q2 | $174M | Sell |
1,092,698
-219,842
| -17% | -$35.9M | 1% | 15 |
|
|
2025
Q1 | $224M | Buy |
1,312,540
+54,871
| +4% | +$9.19M | 1.4% | 8 |
|
|
2024
Q4 | $211M | Buy |
1,257,669
+187,839
| +18% | +$32M | 1.21% | 12 |
|
|
2024
Q3 | $185M | Sell |
1,069,830
-44,037
| -4% | -$7.48M | 1.06% | 15 |
|
|
2024
Q2 | $184M | Buy |
1,113,867
+58,360
| +6% | +$9.54M | 1.11% | 13 |
|
|
2024
Q1 | $171M | Buy |
1,055,507
+19,557
| +2% | +$3.07M | 1.1% | 15 |
|
|
2023
Q4 | $152M | Sell |
1,035,950
-104,919
| -9% | -$15.5M | 1.05% | 15 |
|
|
2023
Q3 | $166M | Buy |
1,140,869
+15,443
| +1% | +$2.36M | 1.18% | 13 |
|
|
2023
Q2 | $171M | Sell |
1,125,426
-98
| -0% | -$14.8K | 1.23% | 10 |
|
|
2023
Q1 | $154M | Sell |
1,125,524
-353,401
| -24% | -$50.5M | 1.07% | 12 |
|
|
2022
Q4 | $224M | Sell |
1,478,925
-102,184
| -6% | -$14.3M | 1.51% | 10 |
|
|
2022
Q3 | $200M | Buy |
1,581,109
+170,701
| +12% | +$24.2M | 1.41% | 10 |
|
|
2022
Q2 | $203M | Buy |
1,410,408
+257,733
| +22% | +$38.7M | 1.67% | 9 |
|
|
2022
Q1 | $176M | Buy |
1,152,675
+157,710
| +16% | +$24.7M | 1.2% | 12 |
|
|
2021
Q4 | $163M | Buy |
994,965
+156,998
| +19% | +$23.3M | 1.04% | 12 |
|
|
2021
Q3 | $117M | Sell |
837,967
-30,666
| -4% | -$4.35M | 0.8% | 17 |
|
|
2021
Q2 | $117M | Sell |
868,633
-259,744
| -23% | -$35.1M | 0.8% | 17 |
|
|
2021
Q1 | $151M | Sell |
1,128,377
-3
| -0% | -$391 | 1.26% | 11 |
|
|
2020
Q4 | $157M | Buy |
1,128,380
+142,454
| +14% | +$19.9M | 1.24% | 11 |
|
|
2020
Q3 | $137M | Buy |
985,926
+126,567
| +15% | +$16.8M | 1.29% | 12 |
|
|
2020
Q2 | $103M | Sell |
859,359
-92,927
| -10% | -$10.8M | 1.08% | 13 |
|
|
2020
Q1 | $116M | Buy |
952,286
+35
| +0% | +$4.2K | 1.29% | 12 |
|
|
2019
Q4 | $119M | Buy |
952,251
+54,013
| +6% | +$6.61M | 1.27% | 12 |
|
|
2019
Q3 | $112M | Sell |
898,238
-55,653
| -6% | -$6.58M | 1.48% | 12 |
|
|
2019
Q2 | $108M | Buy |
953,891
+230,953
| +32% | +$24.6M | 1.34% | 14 |
|
|
2019
Q1 | $79M | Sell |
722,938
-55,733
| -7% | -$5.43M | 1.01% | 15 |
|
|
2018
Q4 | $71.6M | Sell |
778,671
-112,192
| -13% | -$10M | 1.1% | 13 |
|
|
2018
Q3 | $74.1M | Buy |
890,863
+123,371
| +16% | +$10.1M | 0.99% | 15 |
|
|
2018
Q2 | $59.9M | Buy |
767,492
+65,792
| +9% | +$4.95M | 0.95% | 15 |
|
|
2018
Q1 | $55.6M | Buy |
701,700
+41,203
| +6% | +$3.44M | 0.95% | 13 |
|
|
2017
Q4 | $60.7M | Buy |
660,497
+97,496
| +17% | +$8.77M | 1.05% | 11 |
|
|
2017
Q3 | $51.2M | Buy |
563,001
+332,722
| +144% | +$30.3M | 0.89% | 15 |
|
|
2017
Q2 | $20.1M | Buy |
230,279
+2,594
| +1% | +$229K | 0.38% | 59 |
|
|
2017
Q1 | $20.5M | Buy |
227,685
+6,607
| +3% | +$586K | 0.4% | 51 |
|
|
2016
Q4 | $18.6M | Sell |
221,078
-203,828
| -48% | -$17.4M | 0.43% | 56 |
|
|
2016
Q3 | $38.1M | Sell |
424,906
-309,659
| -42% | -$26.9M | 0.92% | 15 |
|
|
2016
Q2 | $62.2M | Sell |
734,565
-120,132
| -14% | -$9.86M | 1.62% | 6 |
|
|
2016
Q1 | $70M | Sell |
854,697
-34,685
| -4% | -$2.79M | 1.75% | 6 |
|
|
2015
Q4 | $70.6M | Buy |
889,382
+274,886
| +45% | +$21M | 1.89% | 7 |
|
|
2015
Q3 | $44.2M | Buy |
614,496
+361,187
| +143% | +$27.1M | 1.09% | 13 |
|
|
2015
Q2 | $19.8M | Buy |
253,309
+40,662
| +19% | +$3.27M | 0.41% | 61 |
|
|
2015
Q1 | $17.4M | Buy |
212,647
+35,626
| +20% | +$3.06M | 0.35% | 72 |
|
|
2014
Q4 | $16.1M | Buy |
+177,021
| New | +$15.6M | 0.34% | 93 |
|
Other funds holding PG
Candriam SCA's PG Position: Q2 2026 in Review
Candriam SCA reduced its Procter & Gamble (PG) stake by 7.4% in Q2 2026, selling an estimated $7.67M and leaving 656,423 shares worth $96.2M. The position accounts for 0.43% of the portfolio, ranked #45.
Candriam SCA first reported a position in PG in Q4 2014 and has held it in 47 quarters since. The position peaked at $224M in Q4 2022. 3,994 funds tracked by Wall St. Rank hold PG as of Q2 2026.
- Candriam SCA held 656,423 shares of Procter & Gamble worth $96.2M as of Q2 2026.
- Candriam SCA sold 52,699 Procter & Gamble shares in Q2 2026, an estimated $7.67M.
- Procter & Gamble made up 0.43% of Candriam SCA's portfolio in Q2 2026, its #45 holding.
- Candriam SCA first reported a position in Procter & Gamble in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Procter & Gamble position peaked at $224M in Q4 2022.
- 3,994 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.